“A doctor making a life or death decision about how to allocate a limited amount of this drug and which patient gets it and which doesn’t — the clinical trials are very important in that regard. They haven’t made that available,” said Rep. Lloyd Doggett, the Texas Democrat who chairs the House Ways and Means Health Subcommittee.
Read the full story here.
********************************************************************
News Credit
Author: Arman Azad and Elizabeth Cohen
Publisher: CNN, reprinted via KSAT
Date: MAy 12, 2020
